跳至主要内容
临床试验/NCT04353323
NCT04353323撤回不适用

Comparison of the Proportion of Covid19 Seroconversion of Caregivers Working or Not in the COVID Sector

University Hospital, Limoges1 个研究点 分布在 1 个国家目标入组 130 人开始时间: 2020年5月25日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
撤回
发起方
入组人数
130
试验地点
1
主要终点
Seroconversion

研究概览

简要总结

According to recent publications, the percentage of caregivers infected with COVID 19 is evaluated between 10 and 30% . This great variability is due, on the one hand to the intensity of the influx of covid plus patients and, on the other hand, to the disparity in the preparation of caregivers in the face of this emergency. Indeed, we can understand that the strict application of hygiene rules can be faulted in the face of the volume of patients, the lack of protective equipment and the lack of specific training for caregivers in this area. As a result, within healthcare teams, there are many questions that generate anxiety: will I be able to provide care properly while protecting myself from the risk of contamination? This anxiety is also present and sometimes manifests itself aggressively in the entourage or in the vicinity of caregivers, due to lack of scientific data adapted to the local ecology of the crisis.

Thus, the aim of this study is to show that the risk for caregivers of being contaminated by COVID in an area dedicated to COVID positive patients is no higher than being a caregiver in a non-COVID area that he either in the adult or pediatric sector.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • caregivers staff assigned to a non-intensive care COVID service
  • or caregivers staff assigned to a non-COVID adult service
  • or caregivers staff assigned to a non-COVID pediatric service
  • Age > = 18 years old
  • With health insurance
  • Express consent

排除标准

  • Protected persons
  • Refusal to participate

研究组 & 干预措施

Covid area

干预措施: Blood sampling (Other)

Non-Covid area

干预措施: Blood sampling (Other)

结局指标

主要结局

Seroconversion

时间窗: Day 30

Participants seroconverion will be assessed by analysing IgG When the seroconverion is confirmed (whenever it occurs), the participant ends his partipation.

Seroconversion

时间窗: Day1

Participants seroconverion will be assessed by analysing IgG When the seroconverion is confirmed (whenever it occurs), the participant ends his partipation.

Seroconversion

时间窗: Day 15

Participants seroconverion will be assessed by analysing IgG When the seroconverion is confirmed (whenever it occurs), the participant ends his partipation.

次要结局

未报告次要终点

研究者

发起方
University Hospital, Limoges
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验